CSL Ltd (CSLLY)

91.67
+0.52(+0.57%)
  • Volume:
    41,000
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    90.76 - 92.09

CSLLY Overview

Prev. Close
91.15
Day's Range
90.76-92.09
Revenue
2.26B
Open
90.76
52 wk Range
85.07-117.24
EPS
4.81
Volume
41,000
Market Cap
86.76B
Dividend (Yield)
1.01
(1.11%)
Average Vol. (3m)
61,908
P/E Ratio
42.56
Beta
0.16
1-Year Change
-17.88%
Shares Outstanding
482,217,446
Next Earnings Date
-
What is your sentiment on CSL?
or
Vote to see community's results!

CSL Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

CSL Ltd Analysis

CSL Ltd Company Profile

CSL Ltd Company Profile

Employees
25000

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell